Global X Scientific Beta Europe ETF
Global X Scientific Beta Europe ETF
Your view on SCID
Overview
What the company does, where it operates, and who runs it.
About Global X Scientific Beta Europe ETF
- Industry
- Asset Management
- Sector
- Financial Services
- CEO
- Not available
- Headquarters
- US
- Industry
- Asset Management
- Sector
- Financial Services
- CEO
- Not available
- Headquarters
- US
The Global X Scientific Beta Europe ETF (SCID) aims to closely track the investment performance, in terms of both price appreciation and income generation, of the Scientific Beta Extended Developed Europe Multi-Beta Multi-Strategy Four-Factor Equal Risk Contribution (ERC) Index, prior to factoring in fees and expenses. To achieve its objective, the fund allocates a minimum of 80% of its total assets to the securities that comprise the underlying index. This allocation also encompasses American Depositary Receipts (ADRs) and Global Depositary Receipts (GDRs) whose value is derived from these index components. The underlying index itself typically includes up to around 600 common stocks listed on European exchanges. The selection of these stocks is governed by an exclusive methodology developed by the index provider.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks the stock is worth vs. the current price.
FRC's fair value estimate for Global X Scientific Beta Europe ETF, and the rating behind it. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Global X Scientific Beta Europe ETF. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Global X Scientific Beta Europe ETF. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Global X Scientific Beta Europe ETF. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Global X Scientific Beta Europe ETF. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Global X Scientific Beta Europe ETF valued side by side against its closest peers. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
Which funds and firms own the stock.
Which institutions hold Global X Scientific Beta Europe ETF, and how their positions are changing. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.
Insider Trading
Recent buying and selling by company executives.
Buying and selling by Global X Scientific Beta Europe ETF executives and directors. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.
Senate Trading
U.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Global X Scientific Beta Europe ETF. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely.
House Trading
U.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Global X Scientific Beta Europe ETF. Representatives' reported transactions in this security, shown next to the company's fundamentals.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Global X Scientific Beta Europe ETF. Press releases and market coverage, newest first.